--- title: "Envista Holdings (NVST) stock: news and investor profile" url: "https://aibio.space/companies/envista/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Envista Holdings Corp (NYSE: NVST), United States. Listing facts, related biotech companies and news on aibio.space." --- NVST Envista Holdings Corp NYSE · United States # Envista Holdings (NVST) news Envista Holdings Corp is a public biotech or pharmaceutical company listed on NYSE under the ticker NVST, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Envista Holdings news We have not published a story on Envista Holdings yet. When there is news, it will appear here. ## Envista Holdings at a glance - **Ticker**: NVST - **Listing**: NYSE - **Country**: United States - **Cash, Jul 3, 2026**: $1.13 billion ### Related companies - [CASTLE BIOSCIENCES INC](https://aibio.space/companies/castle-biosciences/) NASDAQ: CSTL - [VivoSim Labs, INC.](https://aibio.space/companies/vivosim-labs/) NASDAQ: VIVS - [INVO Fertility](https://aibio.space/companies/invo-fertility/) NASDAQ: IVF - [SANUWAVE Health](https://aibio.space/companies/sanuwave-health/) NASDAQ: SNWV - [ORASURE TECHNOLOGIES INC](https://aibio.space/companies/orasure-technologies/) NASDAQ: OSUR - [Global Innovative Platforms](https://aibio.space/companies/global-innovative-platforms/) OTC: GIPL - [OPKO HEALTH, INC.](https://aibio.space/companies/opko-health/) NASDAQ: OPK - [PyroGenesis Canada](https://aibio.space/companies/pyrogenesis-canada/) OTC: PYRGF ### Also on NYSE - [HAEMONETICS CORP](https://aibio.space/companies/haemonetics/) HAE - [MSA Safety](https://aibio.space/companies/msa-safety/) MSA - [REVVITY, INC.](https://aibio.space/companies/revvity/) RVTY - [Stereotaxis](https://aibio.space/companies/stereotaxis/) STXS - [MYOMO, INC.](https://aibio.space/companies/myomo/) MYO - [Pfizer](https://aibio.space/companies/pfizer-pfe/) PFE ## Envista Holdings annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$114.0 million](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/) | [$99.1 million](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/) | | Net income (loss) | [$47.0 million](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/) | [-$1.12 billion](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/) | | Cash from operations | [$275.7 million](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/) | [$336.5 million](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/) | | Cash and equivalents | [$1.21 billion](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000066/) | [$1.07 billion](https://www.sec.gov/Archives/edgar/data/1757073/000175707326000011/) | Latest balance sheet, Jul 3, 2026 (10-Q): cash and equivalents $1.13 billion. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Envista Holdings What is the ticker symbol of Envista Holdings? Envista Holdings Corp trades under the ticker NVST on NYSE. Where is Envista Holdings listed? Envista Holdings Corp is listed on NYSE. Which country or territory is Envista Holdings listed under? Our directory records Envista Holdings Corp under United States. Does aibio.space cover Envista Holdings? aibio.space lists Envista Holdings Corp among 2,820 public biotech companies and publishes its news here as stories appear. Is Envista Holdings profitable? Envista Holdings Corp reported net income of $47.0 million for the fiscal year ended Dec 31, 2025, and generated $275.7 million of cash from operations, per its annual report to the SEC. How much does Envista Holdings spend on research and development? $114.0 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Envista Holdings have? $1.13 billion in cash at Jul 3, 2026, per its 10-Q. ## Investor discussion: Envista Holdings Members talk about Envista Holdings (NVST). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:NVST on TradingView](https://www.tradingview.com/symbols/NYSE-NVST/). ## Listing details Envista Holdings Corp is a public biotech or pharmaceutical company listed on NYSE under the ticker NVST, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Envista Holdings Corp - **Ticker**: NVST - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/envista/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Envista Holdings (NVST) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/envista/